NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 2 Apr · 15:14 IST

Neuland Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.7%1-day move
₹12635.00
prior close
₹12469.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.6-0.5+3.7+3.8+11.6+16.5+18.3+19.0+16.9+27.4+33.7+50.3
Up moveDown movePending
AI summary

Neuland Laboratories Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The certificate was issued by Kfin Technologies Limited, the company's Registrar and Share Transfer Agent. The filing confirms that details of securities that were dematerialized or rematerialized during the quarter have been properly furnished to both BSE and NSE, where the company's shares are listed. This is a routine quarterly compliance requirement mandated by SEBI regulations to ensure transparency in share dematerialization activities. No material developments or changes to share capital are indicated in this filing.

Likely market impact

No direct impact on shareholders or stock price. This is a standard regulatory compliance filing that confirms proper processing of share dematerialization and rematerialization requests during the quarter. Investors should not interpret this as a significant corporate event.